In the present report, I attempted to identify the nature of humoral and cellular factors in heterotransplantation immunity, assuming that the former would confer on the animals transplantation immunity by passive immunization with serum, while the latter would be adoptively transferred to recipients with sensitized cells.
A group of mice was inoculated with rat ascites hepatoma cells. Eighteen to 23 days after the transplantation, the serum and nucleated cells were collected from the peritoneal fluid, spleen and mesenteric lymph node were pooled separate ly. Then, the extraction of effective substances was performed by treatment of the specimens with sonic oscillation, salting out with ammonium sulfate, Sephadex column chromatography, sucrose density gradient centrifugation, etc.
1. The active factor in immune sera was found to be 7S IgG, whereas no high molecular immunoglobulin effective in accelerating the rejection of target cells could be found. 2 As regards transplantation immunity, there have been many reports available which indicate the importance of either humoral or cellular immunity. Mitchison6 and Billingham et al.7 succeeded in conferring homotransplantation immunity to transplantable tumor cells or skin grafts on normal mice by transferring the cells of regional lymph node collected from the mice which had previously been transplanted with the respective cells, and this kind of immunity has been called 'adoptive immunity'. Since the serum from the mice of which lymph node cells demonstrated the ability of adoptive immunity failed to confer homotransplantation immunity on normal mice, the role of the cellular factor(s) in homotransplantation immunity has been regarded to be more important than that of the humoral factor(s).
By contrast, in immunity to heterotransplantation, the importance of humoral antibodies has been shown by many experimental data. For instance, the serum from animals, previously transplanted with heterologous tissue or cells, not only demonstrated cytotoxic effect on the target cells in vitro, but also conferred on normal animals, the capacity to reject acceleratedly the target cells by passive immunization. In consequence of such prominent effectiveness of humoral antibody, the role of cellular factors has been disregarded in heterotransplantation immunity. Determination of effectiveness in heterotransplantation immunity. An appropriate dilution of heat-inactivated immune serum or of fractions extracted from the immune serum was injected intraperitoneally into a number of mice, and immediately after the injection the mice were transplanted intraperitoneally with 106 AH 39 cells. In the case of 'immune' cells, a number of mice was trans ferred intraperitoneally with a definite number of oscillated or heat-inactivated ' immune' cells or with an appropriately diluted 'immune' cell extract, and 6 to 12 hours after the transfer, the mice were intraperitoneally transplanted with 106 AH 39 cells. After the transplantation, a small amount of peritoneal fluid was withdrawn from the mice with a fine glass capillary at intervals , and Giemsa stained preparations of smeared peritoneal fluid were made. The stained preparations were examined under a microscope, and it was determined whether the transplanted AH 39 cells were rejected. Because the transplanted AH 39 cells were usually rejected in normal dd-mice between 7 and 9 days after the transplantation, the test material was regarded to contain effective substance for conferring heterotransplantation immunity on normal mice , when AH 39 cells were rejected within 6 days after the transplantation by the mice which were injected with the material to be examined .
Anti-mouse lymphocyte serum. Anti-mouse lymphocyte serum was prepared according to Sacks' method.9 The mesenteric lymph nodes were collected from a number of adult mice after the blood had been removed from the circulation with a large amount of physiological saline containing sodium citrate which was injected into the left heart ventricle and overflowed from the right heart ventricle . Lymph node cell suspension were prepared by forcibly passing the mesenteric lymph nodes through a steel tissue press. An appropriate amount of the lymph node cell suspension was injected into the skin and the peritoneal cavity of the rabbit every day for 3 weeks. Then the serum was collected from the rabbit and used as anti-mouse lymphocyte serum without absorption of anti mouse erythrocyte antibody. RESULTS 
AND DISCUSSION
1. Divergence of humoral and cellular immunity in induction of immunological tolerance to AH 39 cells It has been proved11 that in dd-mice the capacity to produce serum antibodies to 0 and H antigens of salmonellae and to sheep erythrocytes develops around 20 days after the birth. So, less than 6 days old mice were transplanted intraperitoneally with AH 39 cells and the time when transplanted AH 39 cells were rejected was determined. Furthermore, cells and serum were collected from the mice when they showed rejection of the transplanted cells, and their effectiveness in conferring the heterotransplantation immunity on normal mice was compared.
As illustrated in Fig. 1 , the mice transplanted with AH 39 cells at the age of 6 days rejected the AH 39 cells between the 7th and 9th day of transplantation like in normal adult mice, while in mice transplanted at the age of 2 or 3 days the AH 39 cells were taken for 14 to 23 days or 15 to 23 days. In mice transplanted with AH 39 cells within 12 hours after the birth, the time of rejection of AH 39 cells was prolonged up to 23 to 34 days after the transplantation. However, even in the mice of this group no death resulted from the growth of the tumor cells. It is noteworthy that the mechanisms of rejection of transplanted AH 39 cells are different according to the age of the mice when the AH 39 cells are transplanted. The serum and spleen cells were collected from the mice of each of the above described groups when they rejected AH 39 cells. After heat inactivation the serum was diluted to 1: 10, and 0.3 ml of the diluted serum was injected into a number of mice. The spleen cells were also inactivated by heating, and 106 of the cells were given to a number of mice. The mice which received the serum or the spleen cells were then transplanted with AH 39 cells, and the effect of the serum or the spleen cells on the rejection of the AH 39 cells was examined. The spleen cells collected from the mice which had been transplanted with AH 39 cells at the age of 6 days conferred the ability to reject acceleratedly the transplanted cells on normal recipient mice, whereas the serum collected from the same mice did not. By contrast, the serum, but not the spleen cells, collected from the mice which had been transplanted with AH 39 cells within 12 hours after the birth, conferred the ability to reject the transplanted cells on normal mice. From these data, it is suggested that immunological tolerance to AH 39 cells is induced only for the cellular immunity but not for the humoral immunity. AH 39 cells transplanted to mice within 12 hours after the birth might induce immunological tolerance concerning the cellular immunity, but the transplanted cells would be rejected later with the development of the ability to produce humoral antibody. The results are shown in Fig. 2 . The ability of the serum to give the hetero transplantation immunity started to increase on the 5th day of transplantation and reached its peak after the 7th day, and the peak value was maintained until the 90th day of transplantation. By contrast , the effectiveness of the cells in immunity producing heterotransplantation started to increase on the second day of transplantation and reached its peak on the 3rd day , but after the rejection of AH 39 cells it decreased rapidly and disappeared between the 40th and 50th day of transplantation.
These results indicate that the immunity to AH 39 cells comprises two essentially different mechanisms , that is, the one is represented by the ability of the cells and the other is represented by the ability of the serum antibody.
Identification of effective substance in immune serum
The serum collected from mice injected with AH 39 cells and killed vaccine of S. enteritidis was passed through a column of Sephadex G-200 and the eluate was divided into fractions of 3.5 ml. Each fraction was determined for its protein content, effectiveness in heterotransplantation immunity, and clearing effect on infecting S. enteritidis.5
The latter effect was regarded to represent the effect of 12.7 S 0 antibody to S. enteritidis. Fig. 3 Fractions of the first and second protein peaks were collected separately and concentrated. Then, they were applied on sucrose density gradient centrifugation. In the case of the first protein peak, O antibody was found between fractions Nos. 9 and 11, but no effective substance for transplantation immunity could be found in any fraction. As for the second protein peak, effective substance for transplantation immunity and H agglutinin to S. enteritidis were found between fractions Nos. 19 and 28. Because H antibody to S. enteritidis has been identified to be 7 S Ig G, the effective substance for heterotransplantation immunity in immune serum must be also 7S Ig G. In this experiment, no immune globulin of macroglobulin nature effective for heterotransplantation immunity could be found in the immune serum. 4. Identification of effective substance in 'immune' cells As shown in Fig. 4 , the effective substance for transplantation immunity of 'immune' cells was found mostly in the first protein peak of the eluate from a Sephadex G-200 column, accompanied with 0 antibody to S. enteritidis, while some weak effectiveness was also found in a portion of the second protein peak. 
Mechanisms of rejection of AH 39 cells by treatment with immune serum
It has been demonstrated by quantitative cultivation of the peritoneal fluid of the infected mice that the mice pre-treated intraperitoneally with a small amount of 0 antibody to S. enteritidis attain an ability rapidly to kill virulent S. enteritidis in their peritoneal cavity, and the phenomenon was called intra peritoneal 'clearance'. 5 This phenomenon, which has been used as a very sensitive method to detect 0 antibody to S. enteritidis, was found to need the co operation of 0 antibody, complement and phagocytic cells.10 So, the experiments were conducted to examine whether a similar condition was necessary for the effective rejection of AH 39 cells from the peritoneal cavity of mice by immune serum.
A state of temporary deprivation of complement in the peritoneal cavity of mice was made by intraperitoneal injection with sensitized sheep erythrocytes, and then the effect of immune serum on intraperitoneally transplanted AH 39 cells was examined in these mice. The results indicated that the effect of immune serum on AH 39 cells was abolished underr the condition of deprivation of complement. In the second experiment, blockade of peritoneal phagocytes of mice was attempted by intraperitoneal injection with 1 mg wet weight of killed bacteria. Immune serum could not exert any effect on AH 39 cells in these mice (Fig. 5) . These results indicate that co-operation of complement and phagocytic cells is necessary for the rejection of AH 39 cells by immune serum as in the case of intraperitoneal "clearance" of infecting S. enteritidis. 6. Mechanisms of rejection of AH 39 cells by treatment with sonicate of 'immune' cells Experiments similar to those described in the preceding section were carried out to examine the mechanism of rejection of AH 39 cells by sonicated 'immune' cells. In the mice deprived of complement by intraperitoneal injection with sensitized sheep erythrocytes, the effect of the 'immune' cell sonicate on AH 39 cells was abolished as in the case of immune serum, indicating the necessity of co-operation with complement for its effect. However, no influence of blockade of peritoneal phagocytes could be observed on the effectiveness of 'immune' cell sonicate (Fig. 6 ), while pretreatment of the recipient mice with anti-mouse lymphocyte serum resulted in abolition of the effect of 'immune' cell sonicate on AH 39 cells (Fig. 7) . These results suggest that the effect of 'immune' cell sonicate could be exerted in co-operation probably with lymphocytes, but not with phagocytic cells. Anti-mouse lymphocyte serum did not influence at all the effectiveness of immune serum.
The results described in the present and the preceding sections indicate that the mechanism of rejection of AH 39 cells by humoral immunity and that by cellular immunity is not similar.
